Pediatric Brain Tumor Trials:

• Phase I dossage escalation study of Topotecan in combination chemotherapy for high risk pediatric brain cancer (IN PED 9701).
  
• Phase II alternating chemotherapy and radiotherapy with peripheral stem cell harvesting for high risk malignant gliomas of childhood (VCC PNO 7244).
  
• Phase II intensive chemotherapy and hyperfractionated radiotherapy for newly diagnosed malignant brain tumors of childhood (VU PBT I.005).
  
• A case-control study of primitive neuroectodermal tumors of the brain in young children (CCG E21).
  
• Phase II study of Temodal in children and adolescents with recurrent central nervous system tumors (CCG AO9701).

For questions regarding clinical protocols call:

Ms. Ester Mitchell
phone (615) 936-0216
fax (615) 936-0223